Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
184 pending office actions • 76 art units • 165 examiners • 0 of 184 (0%) have an AI response strategy ready • 123 patents granted in the last 365 days
The Johns Hopkins University manages a portfolio with 186 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 79 distinct art units, showcasing the university's research and development reach. The prosecution involves 168 distinct examiners, which means that the count of pending cases is higher than the count of examiners assigned to them.
SCHLOOP, ALLISON ELIZABETH is the busiest examiner for the portfolio, currently overseeing 3 pending office actions. Despite the total of 186 pending office actions, the workload is distributed, as evidenced by the 168 distinct examiners assigned. This count of 79 distinct art units requires a prosecution strategy to address the specific technical nuances of many different specialized groups within the Biotechnology & Pharmaceuticals sector. The distribution of cases ensures that the university's patenting outcomes are spread across many individuals, with the busiest examiner handling only 3 of the pending matters.
Based on the USPTO statutory response window for each pending office action. 67 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 67 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 4 (2%) |
| §101 + other | 20 (11%) |
| §103 only | 40 (22%) |
| §102 only | 5 (3%) |
| §112 only | 10 (5%) |
| Double-patenting only | 3 (2%) |
| Double-patenting + other | 24 (13%) |
| Multi-statute (no §101) | 76 (41%) |
| No statute on record | 2 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHLOOP, ALLISON ELIZABETH | 3 | 63.0% | +56.5% |
| PERREIRA, MELISSA JEAN | 2 | 52.0% | +25.8% |
| KENNEDY, SARAH JANE | 2 | 0.0% | +0.0% |
| SAMALA, JAGADISHWAR RAO | 2 | 68.0% | +55.6% |
| CHERNYSHEV, OLGA N | 2 | 54.5% | +34.4% |
| LEWOCZKO, EVAN MICHAEL | 2 | — | — |
| HEASLEY, MEGHAN CHRISTINE | 2 | 75.2% | +34.0% |
| KIM, DANIELLE A | 2 | 37.1% | +56.3% |
| HOWELL, THEODORE R | 2 | 66.8% | +25.3% |
| GRAY, JESSICA | 2 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16763827 | COMPOSITIONS AND METHODS FOR EFFICIENT GENOME EDITING | WHITEMAN, BRIAN A | 146d overdue |
| 18030465 | DETECTION OF ACE2 IgM AUTOANTIBODIES AS MARKERS OF SEVERITY AND MECHANISM IN COVID19 PATIENTS | GILL, RACHEL B | 124d overdue |
| 18850458 | Leg Support for Orthopaedic Surgery | RODRIQUEZ, KARI KRISTIN | 104d overdue |
| 18255767 | COMPOUNDS AND THEIR USE FOR TREATING NEUROPATHIC PAIN | MARTIN, KEVIN STEPHEN | 78d overdue |
| 18261366 | METHODS OF DETECTING HIGH RISK BARRETT'S ESOPHAGUS WITH DYSPLASIA, AND ESOPHAGEAL ADENOCARCINOMA | DAUNER, JOSEPH G | 77d overdue |
| 18698097 | AUTOMATIC RADIOTHERAPY PRESCRIPTION ANOMALY DETECTION | COBANOGLU, DILEK B | 56d overdue |
| 17550542 | BIOMIMETIC ANISOTROPIC POLYMERIC PARTICLES WITH NATURALLY DERIVED CELL MEMBRANES FOR ENHANCED DRUG DELIVERY | DONOHUE, SEAN R | 53d overdue |
| 18441540 | System And Method For Displaying An Image | SHAFQAT, AMY JEANETTE | 52d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18990863 | IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA) | PERREIRA, MELISSA JEAN | 78d overdue |
| 18107336 | METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION | HOWELL, THEODORE R | 78d overdue |
| 18376127 | METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION | HOWELL, THEODORE R | 50d overdue |
| 17771772 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ESOPHAGEAL CANCER | SCHLOOP, ALLISON ELIZABETH | 46d overdue |
| 18380984 | NanoMesh Drug Delivery for Treatment of Brain Tumors | KIM, DANIELLE A | 25d overdue |
| 18657340 | CITRULLINATED BRAIN AND NEUROLOGICAL PROTEINS AS BIOMARKERS OF BRAIN INJURY OR NEURODEGENERATION | CHERNYSHEV, OLGA N | 8d overdue |
| 18550371 | DELIVERY OF MACROMOLECULES USING MICROINJECTORS | KIM, DANIELLE A | 34d |
| 18548423 | ANTI-FIBROTIC THERAPIES | HEASLEY, MEGHAN CHRISTINE | 42d |
| Art Unit | Apps |
|---|---|
| 1618 | 11 |
| 1682 | 10 |
| 1683 | 6 |
| 3798 | 5 |
| 2877 | 5 |
| 1675 | 5 |
| 3791 | 5 |
| 1619 | 4 |
| 1626 | 4 |
| 1636 | 4 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19482406 | OPERATOR-INDEPENDENT ULTRASOUND IMAGING | FRITH, SEAN A | 3798 | §102§103 | Non-Final OA | — | Pending | Nov 07, 2025 |
| 19286066 | REAL-TIME ULTRASOUND MONITORING FOR ABLATION THERAPY | BYKHOVSKI, ALEXEI | — | §102§103 | Non-Final OA | — | Pending | Jul 30, 2025 |
| 19238047 | ROBOTIC TASK COMPLETION FROM NATURAL LANGUAGE REQUESTS | HANNAN, B M M | 3657 | §101§112 | Non-Final OA | — | Pending | Jun 13, 2025 |
| 19136781 | Vehicle Recovery System | CURRY, CINDI M | 3642 | §102§103§112 | Non-Final OA | — | Pending | Jun 06, 2025 |
| 19174285 | NEUROMODULATION BASED NERVE IDENTIFICATION | MATTSON, SEAN D | 3798 | §103§112Other | Non-Final OA | 36d | Pending | Apr 09, 2025 |
| 19112143 | MACHINE LEARNING SYSTEMS AND RELATED ASPECTS FOR THE DETECTION OF DISEASE STATES | ELSHAER, ALAAELDIN M | 3687 | §101§102§103 | Final Rejection | — | Pending | Mar 14, 2025 |
| 18997669 | LATTICE HEATSINK FOR IMPINGEMENT COOLING | RUBY, TRAVIS C | — | §102 | Non-Final OA | — | Pending | Jan 22, 2025 |
| 18877461 | METHODS AND RELATED ASPECTS FOR CHARACTERIZING LABELED NANOPARTICLES | RIZVI, AKBAR HASSAN | 2877 | §103 | Non-Final OA | — | Pending | Dec 20, 2024 |
| 18990863 | IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA) | PERREIRA, MELISSA JEAN | 1618 | §103DP | Final Rejection | 78d overdue | Pending | Dec 20, 2024 |
| 18972277 | IN SITU NUCLEIC ACID ANALYSIS USING PROBE PAIR LIGATION | KENNEDY, SARAH JANE | 1682 | §112 | Final Rejection | — | Pending | Dec 06, 2024 |
| 18871568 | DETECTING BINOCULAR EYE ALIGNMENT USING SIGNAL CORRELATION | BOURQUINE, MACKENZI TATE | 2872 | §102§103 | Non-Final OA | — | Pending | Dec 04, 2024 |
| 18869346 | NON-ACID INHIBITORS OF INOSITOL HEXAKISPHOSPHATE KINASE (IP6K) AND METHODS OF USE THEREOF | MOORE, SUSANNA | — | §102§112DP | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18947884 | SYSTEMS AND METHODS FOR COLLECTING ORBITAL DEBRIS | GAITONDE, MEGHA MEHTA | — | §102§103 | Non-Final OA | — | Pending | Nov 14, 2024 |
| 18935852 | PROVIDING SENSORY STIMULATIONS VIA PHOTOACOUSTIC, PIEZO-BASED, THERMAL, AND/OR ELECTRICAL EFFECTS | JOHNSON, NICOLE F | — | §103Other | Non-Final OA | — | Pending | Nov 04, 2024 |
| 18861291 | PENEM ANTIBACTERIALS AGAINST MYCOBACTERIAL PATHOGENS AND D,D- AND L,D TRANSPEPTIDASES | BRAUN, MADELINE E | — | §102§103§112DP | Non-Final OA | — | Pending | Oct 29, 2024 |
| 18857693 | Device for Early Detection of Pediatric IV Infiltration | SCHMIDT, EMILY LOUISE | — | §102§103 | Non-Final OA | — | Pending | Oct 17, 2024 |
| 18855981 | METHOD OF MEASURING LEVEL OF IMMUNE SUPPRESSION | DRISCOLL, LORA E BARNHART | — | §101§102§103 | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18855172 | INTERACTIVE TOOL TO IMPROVE RISK PREDICTION AND CLINICAL CARE FOR A DISEASE THAT AFFECTS MULTIPLE ORGANS | EVANS, TRISTAN ISAAC | 3683 | §101§112 | Final Rejection | — | Pending | Oct 08, 2024 |
| 18854746 | IMPROVED RAMAN SPECTROSCOPY AND COMBINED RAMAN-MATRIX-ASSISTED LASER DESORPTION/IONIZATION (MALDI) IMAGING WORKFLOW WITH THE ADDITION OF AROMATIC COMPOUNDS | RAHMAN, MD M | 2877 | §102§103 | Non-Final OA | — | Pending | Oct 07, 2024 |
| 18854168 | METHODS AND MATERIALS FOR TREATING SYNGAP1-ASSOCIATED NEURODEVELOPMENTAL DISORDERS | CANDELARIA, JULIANA IRENE | — | §102§103§112 | Non-Final OA | — | Pending | Oct 04, 2024 |
| 18850458 | Leg Support for Orthopaedic Surgery | RODRIQUEZ, KARI KRISTIN | 3786 | §102§112 | Final Rejection | 104d overdue | Pending | Sep 24, 2024 |
| 18847731 | ADDITIVE MANUFACTURING OF ULTRA-HIGH-TEMPERATURE CERAMICS | YANG, JIE | — | §102§103§112DP | Non-Final OA | — | Pending | Sep 17, 2024 |
| 18883232 | RAPID ANEUPLOIDY DETECTION | CHUNDURU, SURYAPRABHA | 1681 | §103DP | Final Rejection | — | Pending | Sep 12, 2024 |
| 18844364 | METHOD AND SYSTEM FOR DELIVERY OF THERAPEUTICS TO EYE | MENSH, ANDREW J | — | §102§103§112 | Non-Final OA | — | Pending | Sep 05, 2024 |
| 18818731 | BIOMARKERS USEFUL IN THE TREATMENT OF SUBJECTS HAVING DISEASES OF THE EYE | RAO, SAVITHA M | — | §102§103DP | Non-Final OA | — | Pending | Aug 29, 2024 |
| 18839307 | FLUID ANALYSIS SYSTEM AND METHODS | AKANBI, ISIAKA O | 2877 | §102 | Final Rejection | — | Pending | Aug 16, 2024 |
| 18839298 | REGISTRATION OF DEFORMABLE STRUCTURES | SOFRONIOU, MICHAEL MARIO | 2661 | §103§112 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18834007 | ORBITAL RESILIENT BLOCKCHAIN-ENABLED INTER-AGENT TRANSACTION SERVICE PROTOCOL | NARRAMORE, BLAKE I | 2438 | §103 | Final Rejection | — | Pending | Jul 29, 2024 |
| 18773723 | SUBMERSIBLE VEHICLE WITH A FLOODABLE ACTUATOR VESSEL | FIGUEROA, MICHAEL KENN POTICANO | — | §103 | Non-Final OA | — | Pending | Jul 16, 2024 |
| 18772628 | PSMA-BINDING AGENTS AND USES THEREOF | SAMALA, JAGADISHWAR RAO | — | DP | Non-Final OA | — | Pending | Jul 15, 2024 |
| 18768619 | HIGH THROUGHPUT ELECTROCHEMICAL EXPERIMENTATION DEVICES AND METHODS | GAMBLE JR, RANDALL LEE | 1795 | §103 | Final Rejection | 55d | Pending | Jul 10, 2024 |
| 18756960 | ITRACONAZOLE ANALOGS AND USE THEREOF | RAO, PADMAJA S | — | §102§103§112Other | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18754996 | SYNTHESIS OF THE RADIOLABELED PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITOR [18F]DCFPYL | SAMALA, JAGADISHWAR RAO | 1618 | §101§102§103DP | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18721824 | COMPOUNDS FOR TREATMENT OF CANCER | NOTTINGHAM, KYLE GREGORY | — | §102§103 | Non-Final OA | — | Pending | Jun 19, 2024 |
| 18715998 | METHODS AND RELATED ASPECTS FOR MITIGATING UNKNOWN BIASES IN COMPUTED TOMOGRAPHY DATA | BEKELE, MEKONEN T | 2699 | §102§103 | Non-Final OA | — | Pending | Jun 03, 2024 |
| 18657340 | CITRULLINATED BRAIN AND NEUROLOGICAL PROTEINS AS BIOMARKERS OF BRAIN INJURY OR NEURODEGENERATION | CHERNYSHEV, OLGA N | 1675 | §112DP | Non-Final OA | 8d overdue | Pending | May 07, 2024 |
| 18705720 | CONTROLLING HOMEOSTATIC REGULATORY CIRCUITRY IN HYPOTHALAMUS | GU, QINHUA | 1633 | §102§112 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18703915 | USE OF BIOMARKERS IN DIAGNOSING AND TREATING LUPUS NEPHRITIS | SODERQUIST, ARLEN | — | §101§102§103§112 | Non-Final OA | — | Pending | Apr 23, 2024 |
| 18630226 | SURFACE-FORMED FIDUCIAL MARKERS AND SURGICAL OBJECT TRACKING | SILVA-AVINA, EMMANUEL | — | §102§103 | Non-Final OA | — | Pending | Apr 09, 2024 |
| 18698097 | AUTOMATIC RADIOTHERAPY PRESCRIPTION ANOMALY DETECTION | COBANOGLU, DILEK B | 3687 | §101 | Non-Final OA | 56d overdue | Pending | Apr 03, 2024 |
| 18694612 | AUTOMATED IDENTIFICATION OF HYPERINTENSIVE APPARENT DIFFUSION COEFFICIENT CLUSTERS FOR MRI-GUIDED LASER INTERSTITIAL THERMAL THERAPY | POPESCU, GABRIEL VICTOR | 3797 | §101§103 | Non-Final OA | 1d overdue | Pending | Mar 22, 2024 |
| 18693636 | MRNA REGULON THERAPY FOR THE TREATMENT OF HAPLOINSUFFICIENCY DISORDERS | GROOMS, TIFFANY NICOLE | — | §101§102§103§112 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18693749 | BIOPSY NEEDLE ACCESSORY | KRETZER, KYLE W. | 3791 | §102§103§112 | Non-Final OA | 19d overdue | Pending | Mar 20, 2024 |
| 18689342 | APTAMER-BASED ELECTROCHEMICAL VIRUS DETECTOR AND METHODS THEREOF | KWAK, DEAN P | — | §102§112Other | Non-Final OA | — | Pending | Mar 05, 2024 |
| 18688195 | CONTROLLED LONG-TERM DRUG DELIVERY AND METHODS THEREOF | OTTON, ALICIA L | 1699 | §102 | Final Rejection | — | Pending | Feb 29, 2024 |
| 18591714 | SYSTEMS AND METHODS OF THERMOCHEMICALLY REDUCING METALLIC ELEMENTS USING THERMAL SHOCK | WANG, NICHOLAS A | — | §102§103 | Non-Final OA | — | Pending | Feb 29, 2024 |
| 18687539 | AUGMENTED REALITY SYSTEM FOR CARDIOPULMONARY RESUSCITATION | RAUBENSTRAW, TYLER ALLEN | — | §102§103 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18581931 | AUTOIMMUNE ANTIBODIES FOR USE IN INHIBITING CANCER CELL GROWTH | WEIDNER, ADAM M | — | §112 | Non-Final OA | — | Pending | Feb 20, 2024 |
| 18684083 | POLYMERS AND NANOPARTICLES FOR INTRAMUSCULAR NUCLEIC ACID DELIVERY | STEINKE, SEAN JAMES | 1619 | §102§103§112Other | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18441540 | System And Method For Displaying An Image | SHAFQAT, AMY JEANETTE | 3798 | §103§112 | Non-Final OA | 52d overdue | Pending | Feb 14, 2024 |
| 18294646 | AGENTS, COMPOSITIONS, AND METHODS FOR CANCER DETECTION | LEWOCZKO, EVAN MICHAEL | — | §103 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18293683 | INHIBITORS OF HYPOXIA-INDUCIBLE FACTORS | CHAO, ALLEN | 1622 | §102§112 | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18423360 | SUPERLATTICE STRUCTURES FOR THERMOELECTRIC DEVICES | ZEC, FILIP | 3763 | Other | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18420857 | METHOD AND APPARATUS FOR PERFORMING MACHINE LEARNING ENRICHED NON-DESTRUCTIVE EVALUATION | DUONG, JOHNNYKHOI BAO | 2667 | §102§103 | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18291122 | SYSTEMS AND METHODS FOR CAPTURE OF CIRCULATING FREE DNA | BELLAH, JEFFREY LAWRENCE | 1683 | §102§103§112Other | Non-Final OA | — | Pending | Jan 22, 2024 |
| 18579227 | COMPOSITIONS AND METHODS FOR TREATING ALPHA-SYNUCLEINOPATHIES | ALDARONDO, DASIA ALI | — | §102§103 | Non-Final OA | — | Pending | Jan 12, 2024 |
| 18411753 | METHODS FOR PREVENTING OR SLOWING THE PROGRESSION OF COGNITIVE DECLINE OR IMPAIRMENT IN SUBJECTS | KUCKLA, ANNA GRACE | 1626 | §102§103§112Other | Non-Final OA | 35d | Pending | Jan 12, 2024 |
| 18404727 | ANTI-FIBROTIC TISSUE RESIDENT MEMORY T CELLS AND USES THEREOF | PRIEST, JESSICA MARIE | — | §102§103§112 | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18571126 | TUNABLE DYNAMIC AND NON-DYNAMIC HYDROGEL SYSTEMS | GALSTER, SAMUEL LEONARD | 1654 | §102§103§112 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18535180 | NONVIRAL GENE TRANSFER TO THE SUPRACHOROIDAL SPACE | BASQUILL, SEAN M | 1614 | §103DP | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18566922 | nSMASE2 INHIBITOR PRODRUGS WITH ENHANCED ORAL AND BRAIN EXPOSURES | HEASLEY, MEGHAN CHRISTINE | 1626 | §103§112 | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18037482 | IMMUNO-ONCOLOGY TARGETS TO IMPROVE T-CELL METABOLIC RESPONSE | LOCKARD, JON MCCLELLAND | — | §112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18289332 | AUTOANTIBODIES FOR USE IN IDENTIFYING DISEASE | BAUSCH, SARAE L | 1699 | §101§102§103§112 | Non-Final OA | — | Pending | Nov 02, 2023 |
| 18495958 | ORGANO-PHOSPHATE MODIFIED METAL ORGANIC FRAMEWORKS AND APPLICATIONS | TAYLOR, JORDAN W | 1738 | §102§103§112 | Non-Final OA | — | Pending | Oct 27, 2023 |
| 18288252 | ESOPHAGEAL SLEEVE DEVICES AND METHODS OF MAKING THE SAME | WOZNICKI, JACQUELINE | 3774 | §102§103§112 | Non-Final OA | 18d overdue | Pending | Oct 25, 2023 |
| 18380984 | NanoMesh Drug Delivery for Treatment of Brain Tumors | KIM, DANIELLE A | 1613 | §103 | Non-Final OA | 25d overdue | Pending | Oct 17, 2023 |
| 18554928 | OPHTHALMIC FORMULATIONS FOR SUSTAINED NEUROPROTECTION | BARBER, KIMBERLY | 1626 | §103 | Non-Final OA | — | Pending | Oct 11, 2023 |
| 18484167 | SURGICAL INSTRUMENT | FERNSTROM, KURT | 3715 | DP | Final Rejection | — | Pending | Oct 10, 2023 |
| 18484137 | ENGINEERED VASCULAR TISSUE MODELS | SCHUBERG, LAURA J | 1631 | §103DP | Non-Final OA | 43d | Pending | Oct 10, 2023 |
| 18286185 | TREATMENT METHODS AND COMPOSITIONS COMPRISING PERAMPANEL | BELL, SARA ELIZABETH | 1625 | §102§103 | Final Rejection | 26d overdue | Pending | Oct 09, 2023 |
| 18553785 | SURFACE ENHANCED RAMAN SPECTROSCOPY METHOD OF PATHOGEN DETECTION AND SUBSTRATE FOR THE SAME | PHILLIPS, RUFUS L | 2877 | §103 | Final Rejection | — | Pending | Oct 03, 2023 |
| 18376127 | METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION | HOWELL, THEODORE R | 1628 | Other | Final Rejection | 50d overdue | Pending | Oct 03, 2023 |
| 18553092 | HETEROBIVALENT AND HOMOBIVALENT AGENTS TARGETING FIBROBLAST ACTIVATION PROTEIN ALPHA AND/OR PROSTATE-SPECIFIC MEMBRANE ANTIGEN | LEWOCZKO, EVAN MICHAEL | 1612 | §102§103§112DP | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18284131 | METHODS OF DETERMINING TREATMENT OUTCOME | GRAY, JESSICA | 1682 | §101§102§103§112 | Final Rejection | 31d overdue | Pending | Sep 26, 2023 |
| 18551557 | K-RAS INHIBITOR | BRADLEY, CHRISTINA | 1654 | §102§112 | Non-Final OA | — | Pending | Sep 20, 2023 |
| 18550371 | DELIVERY OF MACROMOLECULES USING MICROINJECTORS | KIM, DANIELLE A | 1613 | §103 | Final Rejection | 34d | Pending | Sep 13, 2023 |
| 18281471 | ENGINEERED IMMUNE CELLS AND USES THEREOF | JUEDES, AMY E | 1644 | §102§103§112 | Non-Final OA | — | Pending | Sep 11, 2023 |
| 18280164 | NUCLEIC ACID DETECTION AND ANALYSIS SYSTEMS | SCHLOOP, ALLISON ELIZABETH | 1683 | §103§112 | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18548767 | DETECTION OF STAGE I LUNG CANCER BIOMARKERS | AGAHI, PUYA | 3791 | §101§103 | Final Rejection | 75d | Pending | Sep 01, 2023 |
| 18280166 | MOLECULAR INDEXING OF PROTEINS BY SELF ASSEMBLY (MIPSA) FOR EFFICIENT PROTEOMIC INVESTIGATIONS | RAYMONDA, MATTHEW HAROLD | 1684 | §103§112DP | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18548423 | ANTI-FIBROTIC THERAPIES | HEASLEY, MEGHAN CHRISTINE | 1626 | §103§112Other | Non-Final OA | 42d | Pending | Aug 30, 2023 |
| 18237744 | NANOFIBER-HYDROGEL COMPOSITES FOR CELL AND TISSUE DELIVERY | MOSS, NATALIE M | 1653 | §103§112 | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18455201 | METHODS OF ENZYMATICALLY REPAIRING CLEAVED RNAS AND DETECTING THEREOF | YOUNG, BRIAN ELLIS | 1682 | §102§103 | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18275586 | BINDING PEPTIDES AND USES THEREOF | MARTINEZ, TARA L | 1654 | §101§112 | Non-Final OA | — | Pending | Aug 02, 2023 |
| 18263644 | SMART PILL DISPENSER | OJOFEITIMI, AYODEJI HARRY | 3651 | §102§103 | Non-Final OA | 5d | Pending | Jul 31, 2023 |
| 18274560 | METHODS FOR INHIBITING CORONAVIRUSES USING SULFORAPHANE | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §103 | Non-Final OA | 22d | Pending | Jul 27, 2023 |
| 18262536 | PATIENT-SPECIFIC BRACHYTHERAPY APPLICATORS | HONRATH, MARC D | 3791 | §102§103§112 | Non-Final OA | — | Pending | Jul 21, 2023 |
| 18224151 | WEARABLE SYSTEM FOR MUSCLE ACTIVITY SENSING AND FEEDBACK | ANTISKAY, BRIAN MICHAEL | 3794 | §103§112 | Final Rejection | 85d | Pending | Jul 20, 2023 |
| 18223331 | MULTI-IMAGER COMPATIBLE ROBOT FOR IMAGE-GUIDED INTERVENTIONS AND FULLY AUTOMATED BRACHYTHERAPY SEED | HONRATH, MARC D | 3791 | §103§112 | Final Rejection | — | Pending | Jul 18, 2023 |
| 18261366 | METHODS OF DETECTING HIGH RISK BARRETT'S ESOPHAGUS WITH DYSPLASIA, AND ESOPHAGEAL ADENOCARCINOMA | DAUNER, JOSEPH G | 1682 | §102§103§112 | Final Rejection | 77d overdue | Pending | Jul 13, 2023 |
| 18268893 | DETECTION OF LUNG CANCER USING CELL-FREE DNA FRAGMENTATION | GRAY, JESSICA | 1682 | §101§103§112Other | Final Rejection | 18d overdue | Pending | Jun 21, 2023 |
| 18257925 | METHODS, SYSTEMS AND RELATED ASPECTS FOR REAL-TIME PREDICTION OF ADVERSE OUTCOMES USING MACHINE LEARNING AND HIGH-DIMENSIONAL CLINICAL DATA | VANNI, GEORGE STEVEN | — | §101§103§112 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18209992 | COMPOSITIONS AND METHODS OF RNA ANALYSIS | POHNERT, STEVEN C | 1683 | §103§112 | Final Rejection | — | Pending | Jun 14, 2023 |
| 18255769 | POLYMERIC NANOPARTICLE COMPOSITIONS FOR ENCAPSULATION AND SUSTAINED RELEASE OF NEUROMODULATORS | JACKSON-TONGUE, LAKIA J | 1645 | §103 | Final Rejection | — | Pending | Jun 02, 2023 |
| 18255630 | RADIOMICS STANDARDIZATION | ZHANG, FAN | 2682 | §103 | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18265118 | SIGNAL | STUBBS, JOHN THOMAS | — | §101§103§112 | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18255767 | COMPOUNDS AND THEIR USE FOR TREATING NEUROPATHIC PAIN | MARTIN, KEVIN STEPHEN | 1624 | §102§112 | Final Rejection | 78d overdue | Pending | Jun 02, 2023 |
| 18255518 | RESTORATION OF MOTOR FUNCTION POST-NEUROLOGICAL INJURY USING PSYCHEDELICS | SIMMONS, CHRIS E | 1622 | §103 | Non-Final OA | — | Pending | Jun 01, 2023 |
| 18039403 | METHODS AND MATERIALS FOR TREATING T CELL CANCERS | MACFARLANE, STACEY NEE | 1675 | §112Other | Non-Final OA | — | Pending | May 30, 2023 |
| 18322237 | SYSTEMS AND METHODS FOR SAFE AND FLEXIBLE BATTERIES | BILLIET, AMANDA JUNE | 1729 | §112 | Non-Final OA | — | Pending | May 23, 2023 |
| 18253231 | PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED PRODRUG FOR SELECTIVE KILLING OF CELLS EXPRESSING PSMA | REYNOLDS, FRED H | 1658 | §102§103§112DPOther | Non-Final OA | 60d | Pending | May 17, 2023 |
| 18315330 | BIOMIMETIC ARTIFICIAL CELLS: ANISOTROPIC SUPPORTED LIPID BILAYERS ON BIODEGRADABLE MICRO AND NANOPARTICLES FOR SPATIALLY DYNAMIC SURFACE BIOMOLECULE PRESENTATION | KASSA, TIGABU | 1619 | §103 | Final Rejection | 70d | Pending | May 10, 2023 |
| 18312196 | ANASTASIS BIOSENSOR CASPASE TRACKER | SU-TOBON, QIWEN NMN | 1636 | §101 | Non-Final OA | — | Pending | May 04, 2023 |
| 18310048 | COMPOSITIONS AND METHODS FOR CELLULAR COMPONENT TRANSFER THERAPY | REGLAS, GILLIAN CHELSEA | 1632 | §102§103DP | Non-Final OA | — | Pending | May 01, 2023 |
| 18033746 | COMPOSITIONS AND METHODS FOR TREATING DISORDERS CHARACTERIZED WITH TGF-BETA ACTIVITY | HOWARD, ZACHARY C | 1674 | §103§112 | Non-Final OA | — | Pending | Apr 25, 2023 |
| 18249676 | INTRINSICALLY-DISORDERED PROTEINS AS EMULSIFIERS | KNIGHT, SAMANTHA JO | 1614 | §103§112 | Final Rejection | 15d | Pending | Apr 19, 2023 |
| 18249314 | SUSTAINED ANTIBODY AND IMMUNOTHERAPEUTIC DELIVERY TO CERVICAL LYMPH NODES | FAUST, AMBER KATHLEEN | 1643 | §103§112 | Non-Final OA | — | Pending | Apr 17, 2023 |
| 18300014 | ANASTASIS BIOSENSOR | KANE, TREVOR LOGAN | 1657 | §101 | Non-Final OA | — | Pending | Apr 13, 2023 |
| 18248722 | ASSESSING A CARDIAC CONDITION INDEPENDENTLY OF PPG WAVEFORM AMPLITUDE ANALYSIS | WEARE, MEREDITH H | 3791 | §101§103§112 | Non-Final OA | 60d | Pending | Apr 12, 2023 |
| 18248834 | ROBOT WATCHDOG | YANCHUS III, PAUL B | 2115 | §103 | Final Rejection | 71d overdue | Pending | Apr 12, 2023 |
| 18030465 | DETECTION OF ACE2 IgM AUTOANTIBODIES AS MARKERS OF SEVERITY AND MECHANISM IN COVID19 PATIENTS | GILL, RACHEL B | 1671 | §101§103 | Non-Final OA | 124d overdue | Pending | Apr 05, 2023 |
| 18194840 | HYPOTONIC MICROBICIDAL FORMULATIONS AND METHODS OF USE | KUCHARCZK, JED A | 1623 | §102§103§112DP | Final Rejection | — | Pending | Apr 03, 2023 |
| 18247579 | SMART SENSOR-EQUIPPED PHANTOM FOR PERFORMANCE ASSESSMENT OF MEDICAL PROCEDURES | GEBREMICHAEL, BRUK A | 3715 | §112 | Non-Final OA | — | Pending | Mar 31, 2023 |
| 18247144 | INTEGRATED PROTEOMIC BIOMARKERS FOR THE DETECTION OF AGGRESSIVE PROSTATE CANCER | DENT, ALANA HARRIS | 1643 | §103§112 | Non-Final OA | — | Pending | Mar 29, 2023 |
| 18187526 | CHEMICAL COMPOSITION | KASSA, TIGABU | 1619 | §103§112 | Non-Final OA | 84d | Pending | Mar 21, 2023 |
| 18027067 | NUCLEIC ACID DETECTION USING A NUCLEASE ACTUATOR | SALVOZA, M FRANCO G | 1672 | §103§112 | Non-Final OA | 84d | Pending | Mar 17, 2023 |
| 18044405 | GALACTOSYLATED DENDRIMERS FOR TARGETED INTRACELLULAR DELIVERY TO HEPATOCYTES | VAN DRUFF, SYDNEY | 1643 | §102§103 | Non-Final OA | — | Pending | Mar 08, 2023 |
| 18167546 | IMPLANTABLE LENS CAPSULE FOR INTRAOCULAR LENS INSERTION | LOPEZ, LESLIE ANN | 3774 | §102§103 | Non-Final OA | — | Pending | Feb 10, 2023 |
| 18107336 | METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION | HOWELL, THEODORE R | 1628 | DP | Final Rejection | 78d overdue | Pending | Feb 08, 2023 |
| 18040858 | IMAGING AND TARGETING PROGRAMMED DEATH LIGAND-1 (PD-L1) EXPRESSION | RICCI, CRAIG D | 1611 | §103DP | Final Rejection | 8d overdue | Pending | Feb 07, 2023 |
| 18015684 | COMPREHENSIVE ANALYSIS OF ANTI-ALLERGEN ANTIBODIES USING PHAGE DISPLAY | ROONEY, NORA MAUREEN | 1641 | §102§103 | Non-Final OA | — | Pending | Jan 11, 2023 |
| 18013864 | METHODS TO GLYCOENGINEER PROTEINS | DAHLE, CHUN WU | 1641 | §102§112 | Final Rejection | 63d | Pending | Dec 29, 2022 |
| 18003462 | GROWTH AND SITE-SPECIFIC ORGANIZATION OF MICRO-SCALE BIMOLECULAR DEVICES ON LIVING CELLS | ROSSI, JULIA ANNE LORRAIN | 1615 | §103§112 | Final Rejection | 14d | Pending | Dec 27, 2022 |
| 18088074 | PROCESSING EVENT DATA BASED ON MACHINE LEARNING | MORALES, PEDRO JESUS | 2124 | §103 | Non-Final OA | 33d | Pending | Dec 23, 2022 |
| 18011071 | NON-INTUITIVE COMBINATION OF DRUG DELIVERY CARRIERS OF THE SAME DRUG FOR SYNERGISTIC GROWTH DELAY OF SOLID TUMORS | YOUNG, MICAH PAUL | 1618 | §103 | Final Rejection | — | Pending | Dec 16, 2022 |
| 18001992 | METHODS AND RELATED ASPECTS FOR OCULAR PATHOLOGY DETECTION | WILLIAMS, REBECCA COLETTE | 2677 | §103 | Non-Final OA | — | Pending | Dec 15, 2022 |
| 18009659 | LINKER-FUNCTIONALIZED METAL-ORGANIC FRAMEWORK FOR POLYSULFIDE TETHERING IN LITHIUM-SULFUR BATTERIES | LEE, JAMES | 1725 | §102 | Non-Final OA | — | Pending | Dec 09, 2022 |
| 17999677 | MAGNETOFLUIDIC CARTRIDGES, DEVICES AND RELATED METHODS OF SAMPLE ANALYSIS | CHIU, MAY LEUNG | 1758 | §103 | Non-Final OA | 5d | Pending | Nov 22, 2022 |
| 17998839 | FUNCTIONAL SKIN COATING POLYMER | BABSON, NICOLE PLOURDE | 1619 | §103§112 | Final Rejection | — | Pending | Nov 15, 2022 |
| 18052804 | PSMA-TARGETING COMPOUNDS AND USES THEREOF | PERREIRA, MELISSA JEAN | 1618 | §112DP | Non-Final OA | — | Pending | Nov 04, 2022 |
| 17922662 | COMPOSITIONS AND METHODS FOR CORONAVIRUS DETECTION | KINSEY WHITE, NICOLE ERIN | 1672 | §112 | Non-Final OA | — | Pending | Nov 01, 2022 |
| 18050809 | PAPANICOLAOU TEST FOR OVARIAN AND ENDOMETRIAL CANCERS | SCHLOOP, ALLISON ELIZABETH | 1683 | §103DP | Non-Final OA | — | Pending | Oct 28, 2022 |
| 17995455 | METHODS AND RELATED ASPECTS FOR EAR PATHOLOGY DETECTION | WOO, JAE KYUN | 3795 | §103 | Non-Final OA | — | Pending | Oct 04, 2022 |
| 17947661 | METHOD AND SYSTEM FOR MONITORING CORNEAL TISSUE HEALTH | DINH, JACK | 2872 | §103 | Final Rejection | — | Pending | Sep 19, 2022 |
| 17816924 | C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN HUMANS | TICHY, JENNIFER M.H. | 1653 | §103 | Final Rejection | — | Pending | Aug 02, 2022 |
| 17873980 | IN SITU FORMING COMPOSITE MATERIAL FOR TISSUE RESTORATION | JONES, DAMERON LEVEST | 1618 | §103§112Other | Non-Final OA | — | Pending | Jul 26, 2022 |
| 17759382 | SELF-ASSEMBLING PRODRUGS AS IMMUNE BOOSTERS FOR CANCER IMMUNOTHERAPY | MOSELEY II, NELSON B | 1642 | §103 | Non-Final OA | 7d | Pending | Jul 25, 2022 |
| 17857698 | APPARATUS FOR THERMAL SENSING DURING ADDITIVE MANUFACTURING AND METHODS THAT ACCOMPLISH THE SAME | REVERMAN, CHAD ANDREW | 2877 | §103 | Non-Final OA | — | Pending | Jul 05, 2022 |
| 17790293 | IN SITU RNA ANALYSIS USING PROBE PAIR LIGATION | KENNEDY, SARAH JANE | 1682 | DPOther | Final Rejection | 72d | Pending | Jun 30, 2022 |
| 17845487 | METHODS FOR ASSESSING RATES OF DNA REPAIR | POHNERT, STEVEN C | 1683 | §103§112 | Final Rejection | — | Pending | Jun 21, 2022 |
| 17737229 | INTRANASAL ADMINISTRATION OF GLUTAMATE CARBOXYPEPTIDASE (GCP-II) INHIBITORS | YOUNG, MICAH PAUL | 1618 | §103 | Non-Final OA | 59d overdue | Pending | May 05, 2022 |
| 17771772 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ESOPHAGEAL CANCER | SCHLOOP, ALLISON ELIZABETH | 1683 | §103DP | Final Rejection | 46d overdue | Pending | Apr 25, 2022 |
| 17771142 | POLYMERIC NANOPARTICLES FOR INTRACELLULAR PROTEIN DELIVERY | ROGERS, JAMES WILLIAM | 1618 | §102§103§112 | Final Rejection | 57d | Pending | Apr 22, 2022 |
| 17770531 | A CRISPR-CAS9 PLATFORM WITH AN INTRINSIC OFF-SWITCH AND ENHANCED SPECIFICITY | REGA, KYLE THOMAS | 1636 | §103 | Final Rejection | — | Pending | Apr 20, 2022 |
| 17768591 | COMPOSITIONS AND METHODS FOR USING ALTERNATIVE SPLICING TO CONTROL SPECIFICITY OF GENE THERAPY | MARVICH, MARIA | 1634 | §102§112 | Final Rejection | — | Pending | Apr 13, 2022 |
| 17715435 | DRUG DELIVERY SYSTEMS AND TARGETED RELEASE OF PHARMACEUTICAL AGENTS WITH FOCUSED ULTRASOUND | LIU, TRACY | 1614 | §103 | Final Rejection | 9d | Pending | Apr 07, 2022 |
| 17767389 | HIGHLY MULTIPLEXED DETECTION OF NUCLEIC ACIDS | ALAM, DANYAL HASSAN | 1600 | §103§112DP | Final Rejection | — | Pending | Apr 07, 2022 |
| 17633917 | BIOMARKERS FOR NEURODEGENERATIVE DISORDERS | FRITCHMAN, REBECCA M | 1758 | §103 | Non-Final OA | 2d overdue | Pending | Feb 08, 2022 |
| 17630104 | METHODS AND COMPOSITIONS FOR HEPATITIS C VIRUS (HCV) | OGUNTADE, ELIZABETH BISOLA | 1677 | §101§103§112DP | Non-Final OA | — | Pending | Jan 25, 2022 |
| 17576503 | ASSAYING OVARIAN CYST FLUID | JOHANNSEN, DIANA B | 1682 | §102§103 | Final Rejection | — | Pending | Jan 14, 2022 |
| 17624440 | IMMOBILIZATION AND QUANTITATIVE MEASUREMENT OF DROPLETS | KRCHA, MATTHEW D | 1796 | §102 | Non-Final OA | — | Pending | Jan 03, 2022 |
| 17623060 | COMPOSITIONS AND METHODS OF TREATING LIVER CANCERS | NESTOR, DONNA MICHELLE | 1627 | §103 | Final Rejection | 107d overdue | Pending | Dec 27, 2021 |
| 17622504 | METHODS AND MATERIALS FOR TARGETED EXPANSION OF REGULATORY T CELLS | PATTERSON, SARAH COOPER | 1675 | §103§112 | Final Rejection | 19d overdue | Pending | Dec 23, 2021 |
| 17550542 | BIOMIMETIC ANISOTROPIC POLYMERIC PARTICLES WITH NATURALLY DERIVED CELL MEMBRANES FOR ENHANCED DRUG DELIVERY | DONOHUE, SEAN R | 1618 | §103§112 | Non-Final OA | 53d overdue | Pending | Dec 14, 2021 |
| 17617233 | INTRAOPERATIVE 'NON-LIFTING' PERIPHERAL NERVE ACTION POTENTIAL RECORDING | TEHRANI, DANIEL | 3792 | §103 | Non-Final OA | 29d overdue | Pending | Dec 07, 2021 |
| 17616740 | DETERMINING CAUSES OF DISEASES SUCH AS CANCER, USING MACHINE LEARNING ANALYSIS OF GENETIC DATA | HAYES, JONATHAN EDWARD | 1685 | §101 | Final Rejection | 22d | Pending | Dec 06, 2021 |
| 17611788 | RAPID ANEUPLOIDY DETECTION | KIM, YOUNG J | 1681 | §103§112 | Final Rejection | 34d | Pending | Nov 16, 2021 |
| 17606605 | COMPOSITIONALLY DEFINED PLASMID DNA/POLYCATION NANOPARTICLES AND METHODS FOR MAKING THE SAME | DUNSTON, JENNIFER ANN | 1637 | §102§103DP | Final Rejection | — | Pending | Oct 26, 2021 |
| 17600843 | LIPID NANOPARTICLES AS ORAL VEHICLES OF IMMUNOTHERAPY | HOERNER, PAUL ELLSWORTH | 1611 | §103§112 | Final Rejection | — | Pending | Oct 01, 2021 |
| 17598690 | METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER | LU, CHENG | 1642 | §102§103§112DP | Non-Final OA | — | Pending | Sep 27, 2021 |
| 17438874 | STICKY PARTICLES FOR EFFICIENT IMAGING | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Non-Final OA | — | Pending | Sep 13, 2021 |
| 17428848 | EXTERNAL AND INTERNAL INTRAOPERATIVE OPTICAL COHERENCE TOMOGRAPHY IMAGING FOR SUBRETINAL MATERIAL DELIVERY | ROBINSON, NICHOLAS A | 3798 | §103 | Non-Final OA | 8d | Pending | Aug 05, 2021 |
| 17422667 | ADHESIVE/ADSORPTION SWITCH ON NANOPARTICLES TO INCREASE TUMOR UPTAKE AND DELAY TUMOR CLEARANCE | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Non-Final OA | 139d overdue | Pending | Jul 13, 2021 |
| 17416399 | RATIOMETRIC FLUORESCENCE CODING METHOD FOR MULTIPLEX NUCLEIC ACID AMPLIFICATION ASSAYS | TURPIN, ZACHARY MARK | 1682 | §103 | Final Rejection | 38d overdue | Pending | Jun 18, 2021 |
| 17344511 | METHOD FOR MANUFACTURING A LOW-PROFILE INTERCRANIAL DEVICE AND THE LOW-PROFILE INTERCRANIAL DEVICE MANUFACTURED THEREBY | BAHENA, CHRISTIE L. | 3774 | §103 | Final Rejection | 47d | Pending | Jun 10, 2021 |
| 17204892 | CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER | MINCHELLA, KAITLYN L | 1685 | §101§103Other | Final Rejection | 5d overdue | Pending | Mar 17, 2021 |
| 17265650 | REVERSIBLE LACRIMAL CANALICULAR OCCLUSION DEVICE | DUBOSE, LAUREN | 3771 | §101§103§112 | Final Rejection | 35d | Pending | Feb 03, 2021 |
| 17264222 | COMPETITIVE PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) BINDING AGENTS FOR REDUCTION OF NON-TARGET ORGAN UPTAKE OF RADIOLABELED PSMA INHIBITORS FOR PSMA POSITIVE TUMOR IMAGING AND RADIOPHARMACEUTICAL THERAPY | DONOHUE, SEAN R | 1618 | §102§103Other | Non-Final OA | 34d | Pending | Jan 28, 2021 |
| 17260943 | INTERNAL LASER LIGHT DELIVERY FOR PHOTOACOUSTIC-GUIDED DRILLING | MULLINS, JESSICA LYNN | 3792 | §103 | Final Rejection | 52d overdue | Pending | Jan 15, 2021 |
| 17139665 | COMPOSITIONS AND METHODS TO ACCELERATE RESOLUTION OF ACUTE LUNG INFLAMMATION | CRAIGO, BAHAR ALAWI | 1699 | §102§103§112Other | Non-Final OA | — | Pending | Dec 31, 2020 |
| 17047006 | NON-INVASIVE DETECTION OF RESPONSE TO IMMUNOTHERAPY | HANEY, AMANDA MARIE | 1682 | §103 | Final Rejection | 72d | Pending | Oct 12, 2020 |
| 16979209 | COMPOSITIONS AND METHODS FOR DETECTING MYCOBACTERIUM TUBERCULOSIS | CHEONG, CHEOM-GIL | 1645 | §112 | Non-Final OA | 53d overdue | Pending | Sep 09, 2020 |
| 16933283 | GEOMETRIC BIOPSY PLAN OPTIMIZATION | EDUN, DEAN NAWAAB | 3797 | §103DPOther | Non-Final OA | 61d | Pending | Jul 20, 2020 |
| 16763827 | COMPOSITIONS AND METHODS FOR EFFICIENT GENOME EDITING | WHITEMAN, BRIAN A | 1636 | §102§103§112 | Non-Final OA | 146d overdue | Pending | May 13, 2020 |
| 16753076 | IMAGE TO WORLD REGISTRATION FOR MEDICAL AUGMENTED REALITY APPLICATIONS USING A WORLD SPATIAL MAP | LI, JOHN DENNY | 3798 | §103§112 | Non-Final OA | — | Pending | Apr 02, 2020 |
| 16809496 | METHOD OF IDENTIFYING RISK FOR AUTISM | HANEY, AMANDA MARIE | 1682 | §112 | Final Rejection | 31d overdue | Pending | Mar 04, 2020 |
| 16612035 | DEVICE TO FACILITATE PERFORMING DESCEMET'S MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK) | DANG, ANH TIEU | 3771 | §102§112 | Non-Final OA | 34d | Pending | Nov 08, 2019 |
| 16556397 | Colorimetric Detection of Organic Amines Using Metal-Organic Frameworks | ADAMS, MICHELLE | 1797 | §102§103§112 | Final Rejection | 70d | Pending | Aug 30, 2019 |
| 16489506 | A NOVEL NERVOUS SYSTEM-SPECIFIC TRANSMEMBRANE PROTEASOME COMPLEX THAT MODULATES NEURONAL SIGNALING THROUGH EXTRACELLULAR SIGNALING VIA BRAIN ACTIVITY PEPTIDES | CHERNYSHEV, OLGA N | 1649 | §112 | Non-Final OA | — | Pending | Aug 28, 2019 |
| 16379763 | IMMORTALIZATION OF CELLS INCLUDING NEURONAL CELLS | DUTT, ADITI | 1675 | §103 | Non-Final OA | — | Pending | Apr 09, 2019 |
| 16226714 | DNA METHYLATION MARKERS FOR METASTATIC PROSTATE CANCER | SU-TOBON, QIWEN NMN | 1636 | §103 | Non-Final OA | — | Pending | Dec 20, 2018 |
| 18438286 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER | GURLEY, JAMI MICHELLE | — | §102§103§112 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18278998 | THERAPEUTIC COMPOSITIONS AND METHODS | CESARE, JOSEPH DAVID | 1675 | §102§103§112 | Non-Final OA | — | Pending | Aug 25, 2023 |
| 18364891 | Click chemistry hydrogel with minimal swelling as a dural sealant and local delivery vehicle for recombinant proteins and other bioactive agents | ATKINSON, JOSHUA ALEXANDER | 1612 | §103DP | Non-Final OA | — | Pending | Aug 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial